• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生存素突变体Thr34Ala的过表达诱导细胞凋亡并抑制胃癌生长。

Overexpression of Survivin mutant Thr34Ala induces apoptosis and inhibits gastric cancer growth.

作者信息

Dang S C, Feng S, Wang P J, Cui L, Qu J G, Zhang J X

出版信息

Neoplasma. 2015;62(1):81-7. doi: 10.4149/neo_2015_010.

DOI:10.4149/neo_2015_010
PMID:25563370
Abstract

UNLABELLED

Survivin is highly expressed in human gastric cancer and correlated with chemoresistance and poor prognosis. In this study, we explored the effect of adeno-associated virus (AAV)-mediated survivin dominant mutant Thr34Ala (rAAV-Sur-Mut(T34A)) on gastric cancer growth. AAV-Sur-Mut (T34A) virus was generated and purified using the AAV vector pAM/CAG-WPRE.poly(A) vector. Cell proliferation was determined by the 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) Assay. Apoptosis was determined by Flow cytometry and Terminal deoxynucleotidyl transferase dUTP nick end labeling. Gene expression was determined by Western blot and immunohistochemistry. Tumor growth was evaluated using a xenograft mouse model. Overexpression of survivin promoted cell growth of gastric cancer cells. Infection of rAAV-Sur-Mut(T34A) virus inhibited cell proliferation, induced apoptosis and sensitized gastric cancer cells to 5-Fluorouracil in vitro. Treatment of rAAV-Sur-Mut(T34A) significantly inhibited cell proliferation, induced apoptosis and inhibited gastric cancer growth in vivo. Our results suggest that the combination of rAAV-Sur-Mut(T34A) and chemotherapy may be a new approach for gastric cancer therapy.

KEYWORDS

Survivin, survivin mutant T34A, adeno-associated virus, gastric cancer, apoptosis, gene therapy.

摘要

未标记

生存素在人类胃癌中高表达,与化疗耐药性和不良预后相关。在本研究中,我们探讨了腺相关病毒(AAV)介导的生存素显性突变体Thr34Ala(rAAV-Sur-Mut(T34A))对胃癌生长的影响。使用AAV载体pAM/CAG-WPRE.poly(A)载体产生并纯化AAV-Sur-Mut (T34A)病毒。通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四氮唑溴盐(MTT)法测定细胞增殖。通过流式细胞术和末端脱氧核苷酸转移酶dUTP缺口末端标记法测定细胞凋亡。通过蛋白质免疫印迹法和免疫组织化学法测定基因表达。使用异种移植小鼠模型评估肿瘤生长。生存素的过表达促进胃癌细胞的生长。rAAV-Sur-Mut(T34A)病毒感染在体外抑制细胞增殖、诱导细胞凋亡并使胃癌细胞对5-氟尿嘧啶敏感。rAAV-Sur-Mut(T34A)治疗在体内显著抑制细胞增殖、诱导细胞凋亡并抑制胃癌生长。我们的结果表明,rAAV-Sur-Mut(T34A)与化疗联合可能是一种新的胃癌治疗方法。

关键词

生存素;生存素突变体T34A;腺相关病毒;胃癌;细胞凋亡;基因治疗

相似文献

1
Overexpression of Survivin mutant Thr34Ala induces apoptosis and inhibits gastric cancer growth.生存素突变体Thr34Ala的过表达诱导细胞凋亡并抑制胃癌生长。
Neoplasma. 2015;62(1):81-7. doi: 10.4149/neo_2015_010.
2
Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer.腺相关病毒介导的survivin 突变体 Thr34Ala 与奥沙利铂协同抑制结肠癌的肿瘤生长和血管生成。
Oncol Rep. 2011 Apr;25(4):1039-46. doi: 10.3892/or.2011.1166. Epub 2011 Jan 28.
3
Gene therapy for colon cancer by adeno-associated viral vector-mediated transfer of survivin Cys84Ala mutant.腺相关病毒载体介导的生存素Cys84Ala突变体转移用于结肠癌的基因治疗
Gastroenterology. 2005 Feb;128(2):361-75. doi: 10.1053/j.gastro.2004.11.058.
4
Inhibition of gastric cancer cell growth in vivo by overexpression of adeno-associated virus-mediated survivin mutant C84A.腺相关病毒介导的survivin 突变 C84A 过表达抑制体内胃癌细胞生长。
Oncol Res. 2013;20(9):411-7. doi: 10.3727/096504013X13657689383094.
5
[Anti-prostate cancer activity of Survivin-T34A mutant in vitro and in vivo].Survivin-T34A突变体在体外和体内的抗前列腺癌活性
Sichuan Da Xue Xue Bao Yi Xue Ban. 2010 May;41(3):390-3.
6
[Preparation of recombinant HIV-TATm-survivin (T34A) protein and its pro-apoptosis activity to cancer cells in vitro].重组HIV-TATm-生存素(T34A)蛋白的制备及其对癌细胞的体外促凋亡活性
Sheng Wu Gong Cheng Xue Bao. 2006 Mar;22(2):285-92. doi: 10.1016/s1872-2075(06)60028-9.
7
[Effects of Survivin-T34A mutant on breast cancer cell in vitro and in vivo].生存素-T34A突变体对乳腺癌细胞的体内外作用
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2014 Jun;31(3):648-51.
8
High-level expression, purification and pro-apoptosis activity of HIV-TAT-survivin (T34A) mutant to cancer cells in vitro.HIV-TAT-生存素(T34A)突变体在体外对癌细胞的高表达、纯化及促凋亡活性
J Biotechnol. 2006 May 29;123(3):367-78. doi: 10.1016/j.jbiotec.2005.11.018. Epub 2006 Jan 10.
9
E2F-1 overexpression inhibits human gastric cancer MGC-803 cell growth in vivo.E2F-1过表达在体内抑制人胃癌MGC-803细胞生长。
World J Gastroenterol. 2015 Jan 14;21(2):491-501. doi: 10.3748/wjg.v21.i2.491.
10
Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli.重组促凋亡显性负性生存素T34A - C84A蛋白在大肠杆菌中的克隆、表达及纯化
Protein Expr Purif. 2019 Aug;160:73-83. doi: 10.1016/j.pep.2019.04.003. Epub 2019 Apr 17.

引用本文的文献

1
Harnessing the Natural Biology of Adeno-Associated Virus to Enhance the Efficacy of Cancer Gene Therapy.利用腺相关病毒的自然生物学特性来提高癌症基因治疗的疗效。
Viruses. 2021 Jun 23;13(7):1205. doi: 10.3390/v13071205.
2
Towards Clinical Implementation of Adeno-Associated Virus (AAV) Vectors for Cancer Gene Therapy: Current Status and Future Perspectives.腺相关病毒(AAV)载体用于癌症基因治疗的临床应用:现状与未来展望
Cancers (Basel). 2020 Jul 14;12(7):1889. doi: 10.3390/cancers12071889.
3
Adeno-associated virus (AAV) vectors in cancer gene therapy.
癌症基因治疗中的腺相关病毒(AAV)载体。
J Control Release. 2016 Oct 28;240:287-301. doi: 10.1016/j.jconrel.2016.01.001. Epub 2016 Jan 12.
4
Correlation between survivin genetic polymorphisms and lung cancer susceptibility.生存素基因多态性与肺癌易感性之间的相关性。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):7426-30. eCollection 2015.